Company / Shareholders' Equity
MARAVAI LIFESCIENCES HOLDINGS, INC. Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$212.4M
FY2025
5-year range
$212.4M / $545.2M
FY2021-FY2025
Trend
-34.7%
vs FY2024
Sector context
#153 of 213
Health Care
What the data says
At $212M, MARAVAI LIFESCIENCES HOLDINGS, INC.'s shareholders' equity ranks #153 of 213 in the Health Care sector. Shareholders' Equity has declined for 3 consecutive years, from $545M in FY2022 to $212M in FY2025.
Based on SEC 10-K filings.
$212M in FY2025 with a 5-year CAGR of +6.5%.
Declined from $417M to $212M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -27.0%
- 5-Year CAGR
- +6.5%
- 10-Year CAGR
- -
Sector benchmark
#153 of 213 in Health CareTop 72% of 213This company $212.4M Sector average $2.5B
▼
-91.7% below sector average
Key checks
Key Insights
- MARAVAI LIFESCIENCES HOLDINGS, INC.'s shareholders' equity has declined for 3 consecutive years.
- 5-year CAGR of +6.5%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 34.7% year-over-year.
- Ranks #153 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $212.4M | -34.7% |
| FY2024 | $325.3M | -21.9% |
| FY2023 | $416.8M | -23.6% |
| FY2022 | $545.2M | +72.8% |
| FY2021 | $315.5M | +103.9% |
| FY2020 | $154.7M | +7.0% |
| FY2019 | $144.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026